Haemonetics | HAE - Stammkapital

Aktienkurs
59.19
Täglich Wechseln
-0.37 -0.62%
Monatlich
-7.85%
Jährlich
-3.01%
Q2 Prognose
55.12




Stammkapital Veränderung Datum
Avanos Medical USD 46.46M 39.46K 2025-12
Baxter International USD 514.28M 168.72M 2025-12
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Boston Scientific USD 1.48B 1.46B 2025-06
Cooper Companies USD 195.1M 3.71M 2025-12
Fresenius EUR 563.24M 0 2025-09
Fresenius Medical Care EUR 279.29M 10.56M 2025-12
Globus Medical USD 135.06M 449K 2025-12
Haemonetics USD 46.83M 82K 2025-12
Hologic USD 222.57M 350K 2025-09
ICU Medical USD 24.69M 2K 2025-12
Intuitive Surgical USD 354.5M 3.98M 2025-12
Masimo USD 52.1M 1000K 2025-12
Medtronic USD 1.28B 1.38M 2025-12
Merit Medical Systems USD 59.29M 72K 2025-09
Neogen USD 217.53M 227K 2025-09
OraSure Technologies USD 70.39M 1.87M 2025-12
Plus Therapeutics USD 138.68M 7.07M 2025-12
Quidel USD 67.9M 200K 2025-09
ResMed USD 145.97M 25K 2025-12
STAAR Surgical USD 49.4M 49K 2025-12
Steris USD 98.15M 344K 2025-12
Stryker USD 382.4M 93K 2025-12
Surmodics USD 14.3M 13.58M 2025-06
Teleflex USD 44.19M 1000 2025-12
Terumo JPY 1.48B 0 2025-12
Thermo Fisher Scientific USD 375.71M 1.9M 2025-12
US Physical Therapy USD 15.2M 0 2025-09
Zimmer Biomet Holdings USD 198.18M 18.44K 2025-12